- Home
- CALC vs SWVL Comparison
CALC vs SWVL Comparison
Compare CALC & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- SWVL
- Stock Information
- Founded
- CALC 2011
- SWVL 2017
- Country
- CALC United States
- SWVL United Arab Emirates
- Employees
- CALC N/A
- SWVL N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- SWVL Business Services
- Sector
- CALC Health Care
- SWVL Consumer Discretionary
- Exchange
- CALC Nasdaq
- SWVL Nasdaq
- Market Cap
- CALC 48.1M
- SWVL 44.5M
- IPO Year
- CALC N/A
- SWVL N/A
- Fundamental
- Price
- CALC $2.91
- SWVL $3.92
- Analyst Decision
- CALC Strong Buy
- SWVL
- Analyst Count
- CALC 2
- SWVL 0
- Target Price
- CALC $14.50
- SWVL N/A
- AVG Volume (30 Days)
- CALC 91.2K
- SWVL 8.8K
- Earning Date
- CALC 08-12-2025
- SWVL 08-26-2025
- Dividend Yield
- CALC N/A
- SWVL N/A
- EPS Growth
- CALC N/A
- SWVL N/A
- EPS
- CALC N/A
- SWVL N/A
- Revenue
- CALC N/A
- SWVL $17,207,362.00
- Revenue This Year
- CALC N/A
- SWVL N/A
- Revenue Next Year
- CALC N/A
- SWVL N/A
- P/E Ratio
- CALC N/A
- SWVL N/A
- Revenue Growth
- CALC N/A
- SWVL N/A
- 52 Week Low
- CALC $1.42
- SWVL $2.40
- 52 Week High
- CALC $5.97
- SWVL $7.50
- Technical
- Relative Strength Index (RSI)
- CALC 52.85
- SWVL 45.46
- Support Level
- CALC $2.31
- SWVL $3.72
- Resistance Level
- CALC $3.00
- SWVL $4.07
- Average True Range (ATR)
- CALC 0.34
- SWVL 0.25
- MACD
- CALC -0.12
- SWVL 0.01
- Stochastic Oscillator
- CALC 40.00
- SWVL 54.56
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.